Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...
After two days of making his case to Senate committees, Robert F. Kennedy Jr.’s bid to lead federal health agencies still ...
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...
A dark money group is attacking a Utah GOP senator's bill meant to protect access to a federal program requiring drug ...
A dark money group is attacking a Utah GOP senator's bill meant to protect access to a federal program requiring drug ...
Unicameral committees start taking testimony at 1:30 p.m. on bills scheduled that day. Livestreams of hearings and texts of ...
The proposed board would be an independent body that would review and set upper payment limits in each step of the supply chain, said Anusha Thotakura, the executive director of Citizen ...
On January 20, a new administration began addressing our nation’s pressing problems, including health care costs. Drug costs ...
Medicaid is a partnership program between states and the federal government to provide healthcare coverage for lower income individuals, people with disabilities, older people, and certain ...
Hoosiers across the spectrum — from employers to employees, and hospitals to insurers — recognize the burden of high health care costs on the state but, as Tuesday’s testimony demonstrated, ...
This bill creates a board, it meaningfully engages a stakeholder council that is appointed in a bipartisan manner and puts ...